For a highly speculative biotech we're not doing too bad considering the macro environment of the past week or so with the broader north american markets getting hammered.  Of course its not just NA taking it on the chin, global markets have pulled back big as well. 

Personally I think this is just a blip, an overdue correction after an incredibly bullish overall market.  Love him or hate him I think Trump's tax cuts are going to swell corporate earnings over the next year....and I can't see that having a negative impact on stock prices over the coming months and into next year at least.

Of course Resverlogix, if + earnings ever do come, they're still a long way off.  Its not unusual to see a stock like RVX taking a big hit in this climate with investors fleeing to safety.  But I'm not even seeing commodities like gold climbing, which I would expect to see if this correction was going to have any long term lasting effect.